Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Many immunomodulatory medications used in dermatology can increase the risk of herpes zoster. Review the use of the recombinant zoster vaccine in patients receiving these drugs.
Review the use of daxibotulinumtoxinA, a unique and longer lasting formulation of botulinum toxin A, approved for treatment of moderate to severe glabellar lines.
This review summarizes the use of topical ruxolitinib, a JAK inhibitor, in various dermatological conditions including vitiligo, alopecia areata, atopic dermatitis, psoriasis, and more.
Review the introduction of Janus kinase inhibitors and their application as the first-line therapeutic option for severe alopecia areata. What might be the future role of JAK inhibitors in this area?